← Back to headlines
Arrowhead Stock Soars on Plozasiran Commercialization Progress
Arrowhead Pharmaceuticals (ARWR) stock reached a new high as its drug Plozasiran moves closer to expanded commercialization.
22 Jul, 19:05 — 22 Jul, 19:05
Sources
Showing 1 of 1 sources
